Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration
-
* Corresponding author: Edward L Tobinick etmd@ucla.edu
Journal of Neuroinflammation 2008, 5:2 doi:10.1186/1742-2094-5-2
Accesses
- Last 30 days: 640 accesses
- Last year: 8119 accesses
- All time: 94579 accesses
Cited by
BioMed Central: 4 citations
|
Research
Karim Belarbi, Timothy Jopson, David Tweedie, Carla Arellano, Weiming Luo, Nigel H Greig, Susanna Rosi Journal of Neuroinflammation 2012, 9:23 (25 January 2012) |
|
Research article
Hong Jiang, Harald Hampel, David Prvulovic, Anders Wallin, Kaj Blennow, Rena Li, Yong Shen Molecular Neurodegeneration 2011, 6:69 (6 October 2011) |
|
Short report
Alzheimer's disease: new diagnostic and therapeutic tools Marco Racchi, Daniela Uberti, Stefano Govoni, Maurizio Memo, Cristina Lanni, Sonya Vasto, Giuseppina Candore, Calogero Caruso, Loriana Romeo, Giovanni Scapagnini Immunity & Ageing 2008, 5:7 (13 August 2008) |
|
Research article
Edward L Tobinick, Hyman Gross BMC Neurology 2008, 8:27 (21 July 2008) Two case reports and further data from a phase II clinical trial support the use of peri-spinal administration of the TNF-alpha inhibitor etanercept to improve verbal abilities in patients with Alzheimer’s disease.
|